141 related articles for article (PubMed ID: 26241398)
1. Primary Mechanisms of Thymosin β4 Repair Activity in Dry Eye Disorders and Other Tissue Injuries.
Sosne G; Kleinman HK
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5110-7. PubMed ID: 26241398
[TBL] [Abstract][Full Text] [Related]
2. Thymosin Beta 4: A Potential Novel Therapy for Neurotrophic Keratopathy, Dry Eye, and Ocular Surface Diseases.
Sosne G; Rimmer D; Kleinman HK; Ousler G
Vitam Horm; 2016; 102():277-306. PubMed ID: 27450739
[TBL] [Abstract][Full Text] [Related]
3. Thymosin β4 significantly reduces the signs of dryness in a murine controlled adverse environment model of experimental dry eye.
Sosne G; Kim C; Kleinman HK
Expert Opin Biol Ther; 2015; 15 Suppl 1():S155-61. PubMed ID: 26096547
[TBL] [Abstract][Full Text] [Related]
4. Thymosin β4: a potential novel dry eye therapy.
Sosne G; Qiu P; Ousler GW; Dunn SP; Crockford D
Ann N Y Acad Sci; 2012 Oct; 1270():45-50. PubMed ID: 23050816
[TBL] [Abstract][Full Text] [Related]
5. Thymosin beta4 and corneal wound healing: visions of the future.
Sosne G; Qiu P; Kurpakus-Wheater M; Matthew H
Ann N Y Acad Sci; 2010 Apr; 1194():190-8. PubMed ID: 20536468
[TBL] [Abstract][Full Text] [Related]
6. Thymosin beta 4 and the eye: the journey from bench to bedside.
Sosne G
Expert Opin Biol Ther; 2018 Jul; 18(sup1):99-104. PubMed ID: 30063853
[TBL] [Abstract][Full Text] [Related]
7. Reversal of second-hand cigarette smoke-induced impairment of corneal wound healing by thymosin beta4 combined with anti-inflammatory agents.
Yuan H; Ma C; Moinet L; Sato N; Martins-Green M
Invest Ophthalmol Vis Sci; 2010 May; 51(5):2424-35. PubMed ID: 20019366
[TBL] [Abstract][Full Text] [Related]
8. Thymosin β4 Promotes Dermal Healing.
Kleinman HK; Sosne G
Vitam Horm; 2016; 102():251-75. PubMed ID: 27450738
[TBL] [Abstract][Full Text] [Related]
9. Thymosin β4 significantly improves signs and symptoms of severe dry eye in a phase 2 randomized trial.
Sosne G; Dunn SP; Kim C
Cornea; 2015 May; 34(5):491-6. PubMed ID: 25826322
[TBL] [Abstract][Full Text] [Related]
10. Thymosin-beta4 modulates corneal matrix metalloproteinase levels and polymorphonuclear cell infiltration after alkali injury.
Sosne G; Christopherson PL; Barrett RP; Fridman R
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2388-95. PubMed ID: 15980226
[TBL] [Abstract][Full Text] [Related]
11. Preservation of tear film integrity and inhibition of corneal injury by dexamethasone in a rabbit model of lacrimal gland inflammation-induced dry eye.
Nagelhout TJ; Gamache DA; Roberts L; Brady MT; Yanni JM
J Ocul Pharmacol Ther; 2005 Apr; 21(2):139-48. PubMed ID: 15857280
[TBL] [Abstract][Full Text] [Related]
12. Thymosin β4: potential to treat epidermolysis bullosa and other severe dermal injuries.
Yang WS; Kang S; Sung J; Kleinman HK
Eur J Dermatol; 2019 Oct; 29(5):459-467. PubMed ID: 31649007
[TBL] [Abstract][Full Text] [Related]
13. Advances in the basic and clinical applications of thymosin β4.
Goldstein AL; Kleinman HK
Expert Opin Biol Ther; 2015; 15 Suppl 1():S139-45. PubMed ID: 26096726
[TBL] [Abstract][Full Text] [Related]
14. Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications.
Goldstein AL; Hannappel E; Sosne G; Kleinman HK
Expert Opin Biol Ther; 2012 Jan; 12(1):37-51. PubMed ID: 22074294
[TBL] [Abstract][Full Text] [Related]
15. The cellular mechanisms of dry eye: from pathogenesis to treatment.
Mantelli F; Massaro-Giordano M; Macchi I; Lambiase A; Bonini S
J Cell Physiol; 2013 Dec; 228(12):2253-6. PubMed ID: 23696296
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory effects of glycine thymosin β4 eye drops in experimental dry eye.
Jin R; Li Y; Li L; Kim DH; Yang CD; Son HS; Choi JH; Yoon HJ; Yoon KC
Biomed Rep; 2020 Jun; 12(6):319-325. PubMed ID: 32382416
[TBL] [Abstract][Full Text] [Related]
17. Trefoil factor family peptide 3 (TFF3) is upregulated under experimental conditions similar to dry eye disease and supports corneal wound healing effects in vitro.
Schulze U; Hampel U; Sel S; Contreras-Ruiz L; Schicht M; Dieckow J; Diebold Y; Paulsen F
Invest Ophthalmol Vis Sci; 2014 May; 55(5):3037-42. PubMed ID: 24713479
[TBL] [Abstract][Full Text] [Related]
18. The regenerative peptide thymosin β4 accelerates the rate of dermal healing in preclinical animal models and in patients.
Treadwell T; Kleinman HK; Crockford D; Hardy MA; Guarnera GT; Goldstein AL
Ann N Y Acad Sci; 2012 Oct; 1270():37-44. PubMed ID: 23050815
[TBL] [Abstract][Full Text] [Related]
19. Thymosin β4 and the vasculature: multiple roles in development, repair and protection against disease.
Dubé KN; Smart N
Expert Opin Biol Ther; 2018 Jul; 18(sup1):131-139. PubMed ID: 30063849
[TBL] [Abstract][Full Text] [Related]
20. Thymosin beta-4 and the eye: I can see clearly now the pain is gone.
Sosne G; Qiu P; Kurpakus-Wheater M
Ann N Y Acad Sci; 2007 Sep; 1112():114-22. PubMed ID: 17495249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
